SC
FLNA

Saturna Capital’s Filana Therapeutics FLNA Stock Holding History

Saturna Capital’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-16,000
Closed -$669K – 156
2022
Q3 		$669K Hold
16,000
– – 0.02% 115
2022
Q2 		$450K Sell
16,000
-37,375
-70% -$944K 0.01% 125
2022
Q1 		$1.98M Sell
53,375
-2,100
-4% -$89K 0.04% 84
2021
Q4 		$2.42M Buy
55,475
+75
+0.1% +$3.93K 0.04% 83
2021
Q3 		$3.44M Buy
55,400
+300
+0.5% +$25K 0.07% 69
2021
Q2 		$4.71M Hold
55,100
– – 0.1% 66
2021
Q1 		$2.48M Buy
55,100
+35,100
+176% +$1.38M 0.06% 76
2020
Q4 		$136K Buy
+20,000
New +$179K ﹤0.01% 171

Other funds holding FLNA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GCM
Gallacher Capital Management Lone Tree, Colorado $261M AUM 17.36% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return